Acute Diarrhea
Conditions
Keywords
probiotic, cost-effectiveness, diarrhea, children, Sum of the monetary cost of the hospitalization
Brief summary
The purpose of this study is to determine whether the probiotic Infloran is cost-effective in treating acute childhood diarrhea.
Detailed description
Probiotics have been proved to shorten duration of diarrhea in children; whether they are cost-effective is less clear. We'd like to validate the use of Infloran, a proprietary probiotic sold in Thailand, in terms of its cost-effectiveness compared to standard diarrhea care in our hospital setting.
Interventions
DRUGProbiotic - Infloran
Drug:Probiotic - Infloran (TM) 1 cap (1 billion CFU of L. acidophilus and 1 billion CFU of B. bifidum) PO bid or tid
Sponsors
Phramongkutklao College of Medicine and Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
3 Months to 6 Years
Healthy volunteers
No
Inclusion criteria
* Children 3 months to 6 years of age * Hospitalized due to acute diarrhea
Exclusion criteria
* History of probiotic treatment in this episode of illness * History of use of other anti-diarrheal medications * Chronic gastrointestinal disease(s) * Severe dehydration * Severe systemic disease(s)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| monetary cost of hospitalization in Thai Baht | from admission to discharge date, approximately 1-7 days |
Secondary
| Measure | Time frame |
|---|---|
| days of hospitalization | from admission to discharge date, approximately 1-7 days |
Countries
Thailand
Outcome results
None listed